AustralieFrV1, PascalFrancis, Corpus, bibRecord, 003184

Global epidemiology of injecting drug use and HIV among people who inject drugs : a systematic review. Commentary

Identifieur interne : 003184 ( PascalFrancis/Corpus ); précédent : 003183; suivant : 003185

Global epidemiology of injecting drug use and HIV among people who inject drugs : a systematic review. Commentary

Auteurs : Kamyar Arasteh ; Don C. Des Jarlais ; Bradley M. Mathers ; Louisa Degenhardt ; Benjamin Phillips ; Lucas Wiessing ; Matthew Hickman ; Steffanie A. Strathdee ; Alex Wodak ; Samiron Panda ; Mark Tyndall ; Abdalla Toufik ; Richard P. Mattick

Source :

Lancet : (British edition) [ 0140-6736 ] ; 2008.

RBID : Pascal:08-0529171

Descripteurs français

Pascal (Inist)
- Toxicomanie, Epidémiologie, Santé publique, Voie intraveineuse, Virus immunodéficience humaine, SIDA, OMS, Médicament, Revue systématique, Médecine, Homme.

English descriptors

KwdEn :
- AIDS, Drug, Drug addiction, Epidemiology, Human, Human immunodeficiency virus, Intravenous administration, Medicine, Public health, Systematic review, WHO.

Abstract

Background Injecting drug use is an increasingly important cause of HIV transmission in most countries worldwide. Our aim was to determine the prevalence of injecting drug use among individuals aged 15-64 years, and of HIV among people who inject drugs. Methods We did a systematic search of peer-reviewed (Medline, EmBase, and PubMed/BioMed Central), internet, and grey literature databases; and data requests were made to UN agencies and international experts. 11022 documents were reviewed, graded, and catalogued by the Reference Group to the UN on HIV and Injecting Drug Use. Findings Injecting drug use was identified in 148 countries; data for the extent of injecting drug use was absent for many countries in Africa, the Middle East, and Latin America. The presence of HIV infection among injectors had been reported in 120 of these countries. Prevalence estimates of injecting drug use could be ascertained for 61 countries, containing 77% of the world's total population aged 15-64 years. Extrapolated estimates suggest that 15.9 million (range 11 .0-21 .2 million) people might inject drugs worldwide; the largest numbers of injectors were found in China, the USA, and Russia, where mid-estimates of HIV prevalence among injectors were 12%, 16%, and 37%, respectively. HIV prevalence among injecting drug users was 20-40% in five countries and over 40% in nine. We estimate that, worldwide, about 3. 0 million (range 0. 8-6.6 million) people who inject drugs might be HIV positive. Interpretation The number of countries in which the injection of drugs has been reported has increased over the last decade. The high prevalence of HIV among many populations of injecting drug users represents a substantial global health challenge. However, existing data are far from adequate, in both quality and quantity, particularly in view of the increasing importance of injecting drug use as a mode of HIV transmission in many regions.

Notice en format standard (ISO 2709)

Pour connaître la documentation sur le format Inist Standard.

A01	`01`	`1`		`@0 0140-6736`
A02	`01`			`@0 LANCAO`
A03		`1`		`@0 Lancet : (Br. ed.)`
A05				`@2 372`
A06				`@2 9651`
A08	`01`	`1`	`ENG`	`@1 Global epidemiology of injecting drug use and HIV among people who inject drugs : a systematic review. Commentary`
A11	`01`	`1`		`@1 ARASTEH (Kamyar) @9 comment.`
A11	`02`	`1`		`@1 DES JARLAIS (Don C.) @9 comment.`
A11	`03`	`1`		`@1 MATHERS (Bradley M.)`
A11	`04`	`1`		`@1 DEGENHARDT (Louisa)`
A11	`05`	`1`		`@1 PHILLIPS (Benjamin)`
A11	`06`	`1`		`@1 WIESSING (Lucas)`
A11	`07`	`1`		`@1 HICKMAN (Matthew)`
A11	`08`	`1`		`@1 STRATHDEE (Steffanie A.)`
A11	`09`	`1`		`@1 WODAK (Alex)`
A11	`10`	`1`		`@1 PANDA (Samiron)`
A11	`11`	`1`		`@1 TYNDALL (Mark)`
A11	`12`	`1`		`@1 TOUFIK (Abdalla)`
A11	`13`	`1`		`@1 MATTICK (Richard P.)`
A14	`01`			`@1 Beth Israel Medical Center, Baron Edmond de Rothschild Chemical Dependency Institute @2 New York, NY 10038 @3 USA @Z 1 aut. @Z 2 aut.`
A14	`02`			`@1 Secretariat of the Reference Group to the UN on HIV and Injecting Drug Use @3 INC @Z 3 aut. @Z 4 aut. @Z 9 aut. @Z 13 aut.`
A14	`03`			`@1 National Drug and Alcohol Research Centre, University of New South Wales @2 Sydney @3 AUS @Z 4 aut. @Z 5 aut. @Z 9 aut. @Z 13 aut.`
A14	`04`			`@1 Crime and Markets Unit, European Monitoring Centre for Drugs and Drug Addiction @2 Lisbon @3 PRT @Z 6 aut.`
A14	`05`			`@1 University of Bristol @2 Bristol @3 GBR @Z 7 aut.`
A14	`06`			`@1 Division of International Health and Cross-Cultural Medicine, University of California @2 San Diego, CA @3 USA @Z 8 aut.`
A14	`07`			`@1 Alcohol and Drug Service, St Vincent's Hospital @2 Sydney @3 AUS @Z 9 aut.`
A14	`08`			`@1 National Institute of Cholera and Enteric Diseases (Indian Council of Medical Research) and Society for Positive Atmosphere and Related Support to HIV/AIDS (SPARSHA) @2 West Bengal @3 IND @Z 10 aut.`
A14	`09`			`@1 British Columbia Centre for Excellence in HIV/AIDS @2 Vancouver, BC @3 CAN @Z 11 aut.`
A14	`10`			`@1 Emerging Trends Department, French Monitoring Centre for Drugs and Drug Addiction @2 Paris @3 FRA @Z 12 aut.`
A17	`01`	`1`		`@1 2007 Reference Group to the UN on HIV and Injecting Drug Use @3 INC`
A20				`@2 1709-1710, 1733-1745 [15 p.]`
A21				`@1 2008`
A23	`01`			`@0 ENG`
A43	`01`			`@1 INIST @2 5004 @5 354000184296890100`
A44				`@0 0000 @1 © 2008 INIST-CNRS. All rights reserved.`
A45				`@0 34 ref.`
A47	`01`	`1`		`@0 08-0529171`
A60				`@1 P @3 AR @3 CT`
A61				`@0 A`
A64	`01`	`1`		`@0 Lancet : (British edition)`
A66	`01`			`@0 GBR`
C01	`01`		`ENG`	@0 Background Injecting drug use is an increasingly important cause of HIV transmission in most countries worldwide. Our aim was to determine the prevalence of injecting drug use among individuals aged 15-64 years, and of HIV among people who inject drugs. Methods We did a systematic search of peer-reviewed (Medline, EmBase, and PubMed/BioMed Central), internet, and grey literature databases; and data requests were made to UN agencies and international experts. 11022 documents were reviewed, graded, and catalogued by the Reference Group to the UN on HIV and Injecting Drug Use. Findings Injecting drug use was identified in 148 countries; data for the extent of injecting drug use was absent for many countries in Africa, the Middle East, and Latin America. The presence of HIV infection among injectors had been reported in 120 of these countries. Prevalence estimates of injecting drug use could be ascertained for 61 countries, containing 77% of the world's total population aged 15-64 years. Extrapolated estimates suggest that 15.9 million (range 11 .0-21 .2 million) people might inject drugs worldwide; the largest numbers of injectors were found in China, the USA, and Russia, where mid-estimates of HIV prevalence among injectors were 12%, 16%, and 37%, respectively. HIV prevalence among injecting drug users was 20-40% in five countries and over 40% in nine. We estimate that, worldwide, about 3. 0 million (range 0. 8-6.6 million) people who inject drugs might be HIV positive. Interpretation The number of countries in which the injection of drugs has been reported has increased over the last decade. The high prevalence of HIV among many populations of injecting drug users represents a substantial global health challenge. However, existing data are far from adequate, in both quality and quantity, particularly in view of the increasing importance of injecting drug use as a mode of HIV transmission in many regions.
C02	`01`	`X`		`@0 002B01`
C02	`02`	`X`		`@0 002B30A01A`
C02	`03`	`X`		`@0 002B30A11`
C03	`01`	`X`	`FRE`	`@0 Toxicomanie @5 01`
C03	`01`	`X`	`ENG`	`@0 Drug addiction @5 01`
C03	`01`	`X`	`SPA`	`@0 Toxicomanía @5 01`
C03	`02`	`X`	`FRE`	`@0 Epidémiologie @5 02`
C03	`02`	`X`	`ENG`	`@0 Epidemiology @5 02`
C03	`02`	`X`	`SPA`	`@0 Epidemiología @5 02`
C03	`03`	`X`	`FRE`	`@0 Santé publique @5 03`
C03	`03`	`X`	`ENG`	`@0 Public health @5 03`
C03	`03`	`X`	`SPA`	`@0 Salud pública @5 03`
C03	`04`	`X`	`FRE`	`@0 Voie intraveineuse @5 05`
C03	`04`	`X`	`ENG`	`@0 Intravenous administration @5 05`
C03	`04`	`X`	`SPA`	`@0 Vía intravenosa @5 05`
C03	`05`	`X`	`FRE`	`@0 Virus immunodéficience humaine @2 NW @5 06`
C03	`05`	`X`	`ENG`	`@0 Human immunodeficiency virus @2 NW @5 06`
C03	`05`	`X`	`SPA`	`@0 Human immunodeficiency virus @2 NW @5 06`
C03	`06`	`X`	`FRE`	`@0 SIDA @5 08`
C03	`06`	`X`	`ENG`	`@0 AIDS @5 08`
C03	`06`	`X`	`SPA`	`@0 SIDA @5 08`
C03	`07`	`X`	`FRE`	`@0 OMS @5 09`
C03	`07`	`X`	`ENG`	`@0 WHO @5 09`
C03	`07`	`X`	`SPA`	`@0 OMS @5 09`
C03	`08`	`X`	`FRE`	`@0 Médicament @5 11`
C03	`08`	`X`	`ENG`	`@0 Drug @5 11`
C03	`08`	`X`	`SPA`	`@0 Medicamento @5 11`
C03	`09`	`X`	`FRE`	`@0 Revue systématique @2 FM @5 12`
C03	`09`	`X`	`ENG`	`@0 Systematic review @2 FM @5 12`
C03	`09`	`X`	`SPA`	`@0 Revisión sistemática @2 FM @5 12`
C03	`10`	`X`	`FRE`	`@0 Médecine @5 17`
C03	`10`	`X`	`ENG`	`@0 Medicine @5 17`
C03	`10`	`X`	`SPA`	`@0 Medicina @5 17`
C03	`11`	`X`	`FRE`	`@0 Homme @5 18`
C03	`11`	`X`	`ENG`	`@0 Human @5 18`
C03	`11`	`X`	`SPA`	`@0 Hombre @5 18`
C07	`01`	`X`	`FRE`	`@0 Lentivirus @2 NW`
C07	`01`	`X`	`ENG`	`@0 Lentivirus @2 NW`
C07	`01`	`X`	`SPA`	`@0 Lentivirus @2 NW`
C07	`02`	`X`	`FRE`	`@0 Retroviridae @2 NW`
C07	`02`	`X`	`ENG`	`@0 Retroviridae @2 NW`
C07	`02`	`X`	`SPA`	`@0 Retroviridae @2 NW`
C07	`03`	`X`	`FRE`	`@0 Virus @2 NW`
C07	`03`	`X`	`ENG`	`@0 Virus @2 NW`
C07	`03`	`X`	`SPA`	`@0 Virus @2 NW`
C07	`04`	`X`	`FRE`	`@0 Virose`
C07	`04`	`X`	`ENG`	`@0 Viral disease`
C07	`04`	`X`	`SPA`	`@0 Virosis`
C07	`05`	`X`	`FRE`	`@0 Infection`
C07	`05`	`X`	`ENG`	`@0 Infection`
C07	`05`	`X`	`SPA`	`@0 Infección`
C07	`06`	`X`	`FRE`	`@0 Immunodéficit @5 37`
C07	`06`	`X`	`ENG`	`@0 Immune deficiency @5 37`
C07	`06`	`X`	`SPA`	`@0 Inmunodeficiencia @5 37`
C07	`07`	`X`	`FRE`	`@0 Immunopathologie @5 39`
C07	`07`	`X`	`ENG`	`@0 Immunopathology @5 39`
C07	`07`	`X`	`SPA`	`@0 Inmunopatología @5 39`
N21				`@1 350`

Format Inist (serveur)

NO :	PASCAL 08-0529171 INIST
ET :	Global epidemiology of injecting drug use and HIV among people who inject drugs : a systematic review. Commentary
AU :	ARASTEH (Kamyar); DES JARLAIS (Don C.); MATHERS (Bradley M.); DEGENHARDT (Louisa); PHILLIPS (Benjamin); WIESSING (Lucas); HICKMAN (Matthew); STRATHDEE (Steffanie A.); WODAK (Alex); PANDA (Samiron); TYNDALL (Mark); TOUFIK (Abdalla); MATTICK (Richard P.)
AF :	Beth Israel Medical Center, Baron Edmond de Rothschild Chemical Dependency Institute/New York, NY 10038/Etats-Unis (1 aut., 2 aut.); Secretariat of the Reference Group to the UN on HIV and Injecting Drug Use/Inconnu (3 aut., 4 aut., 9 aut., 13 aut.); National Drug and Alcohol Research Centre, University of New South Wales/Sydney/Australie (4 aut., 5 aut., 9 aut., 13 aut.); Crime and Markets Unit, European Monitoring Centre for Drugs and Drug Addiction/Lisbon/Portugal (6 aut.); University of Bristol/Bristol/Royaume-Uni (7 aut.); Division of International Health and Cross-Cultural Medicine, University of California/San Diego, CA/Etats-Unis (8 aut.); Alcohol and Drug Service, St Vincent's Hospital/Sydney/Australie (9 aut.); National Institute of Cholera and Enteric Diseases (Indian Council of Medical Research) and Society for Positive Atmosphere and Related Support to HIV/AIDS (SPARSHA)/West Bengal/Inde (10 aut.); British Columbia Centre for Excellence in HIV/AIDS/Vancouver, BC/Canada (11 aut.); Emerging Trends Department, French Monitoring Centre for Drugs and Drug Addiction/Paris/France (12 aut.)
DT :	Publication en série; Article; Commentaire; Niveau analytique
SO :	Lancet : (British edition); ISSN 0140-6736; Coden LANCAO; Royaume-Uni; Da. 2008; Vol. 372; No. 9651; 1709-1710, 1733-1745 [15 p.]; Bibl. 34 ref.
LA :	Anglais
EA :	Background Injecting drug use is an increasingly important cause of HIV transmission in most countries worldwide. Our aim was to determine the prevalence of injecting drug use among individuals aged 15-64 years, and of HIV among people who inject drugs. Methods We did a systematic search of peer-reviewed (Medline, EmBase, and PubMed/BioMed Central), internet, and grey literature databases; and data requests were made to UN agencies and international experts. 11022 documents were reviewed, graded, and catalogued by the Reference Group to the UN on HIV and Injecting Drug Use. Findings Injecting drug use was identified in 148 countries; data for the extent of injecting drug use was absent for many countries in Africa, the Middle East, and Latin America. The presence of HIV infection among injectors had been reported in 120 of these countries. Prevalence estimates of injecting drug use could be ascertained for 61 countries, containing 77% of the world's total population aged 15-64 years. Extrapolated estimates suggest that 15.9 million (range 11 .0-21 .2 million) people might inject drugs worldwide; the largest numbers of injectors were found in China, the USA, and Russia, where mid-estimates of HIV prevalence among injectors were 12%, 16%, and 37%, respectively. HIV prevalence among injecting drug users was 20-40% in five countries and over 40% in nine. We estimate that, worldwide, about 3. 0 million (range 0. 8-6.6 million) people who inject drugs might be HIV positive. Interpretation The number of countries in which the injection of drugs has been reported has increased over the last decade. The high prevalence of HIV among many populations of injecting drug users represents a substantial global health challenge. However, existing data are far from adequate, in both quality and quantity, particularly in view of the increasing importance of injecting drug use as a mode of HIV transmission in many regions.
CC :	002B01; 002B30A01A; 002B30A11
FD :	Toxicomanie; Epidémiologie; Santé publique; Voie intraveineuse; Virus immunodéficience humaine; SIDA; OMS; Médicament; Revue systématique; Médecine; Homme
FG :	Lentivirus; Retroviridae; Virus; Virose; Infection; Immunodéficit; Immunopathologie
ED :	Drug addiction; Epidemiology; Public health; Intravenous administration; Human immunodeficiency virus; AIDS; WHO; Drug; Systematic review; Medicine; Human
EG :	Lentivirus; Retroviridae; Virus; Viral disease; Infection; Immune deficiency; Immunopathology
SD :	Toxicomanía; Epidemiología; Salud pública; Vía intravenosa; Human immunodeficiency virus; SIDA; OMS; Medicamento; Revisión sistemática; Medicina; Hombre
LO :	INIST-5004.354000184296890100
ID :	08-0529171

Links to Exploration step

Pascal:08-0529171

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Global epidemiology of injecting drug use and HIV among people who inject drugs : a systematic review. Commentary</title>
<author><name sortKey="Arasteh, Kamyar" sort="Arasteh, Kamyar" uniqKey="Arasteh K" first="Kamyar" last="Arasteh">Kamyar Arasteh</name>
<affiliation><inist:fA14 i1="01"><s1>Beth Israel Medical Center, Baron Edmond de Rothschild Chemical Dependency Institute</s1>
<s2>New York, NY 10038</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Des Jarlais, Don C" sort="Des Jarlais, Don C" uniqKey="Des Jarlais D" first="Don C." last="Des Jarlais">Don C. Des Jarlais</name>
<affiliation><inist:fA14 i1="01"><s1>Beth Israel Medical Center, Baron Edmond de Rothschild Chemical Dependency Institute</s1>
<s2>New York, NY 10038</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Mathers, Bradley M" sort="Mathers, Bradley M" uniqKey="Mathers B" first="Bradley M." last="Mathers">Bradley M. Mathers</name>
<affiliation><inist:fA14 i1="02"><s1>Secretariat of the Reference Group to the UN on HIV and Injecting Drug Use</s1>
<s3>INC</s3>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>13 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Degenhardt, Louisa" sort="Degenhardt, Louisa" uniqKey="Degenhardt L" first="Louisa" last="Degenhardt">Louisa Degenhardt</name>
<affiliation><inist:fA14 i1="02"><s1>Secretariat of the Reference Group to the UN on HIV and Injecting Drug Use</s1>
<s3>INC</s3>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>13 aut.</sZ>
</inist:fA14>
</affiliation>
<affiliation><inist:fA14 i1="03"><s1>National Drug and Alcohol Research Centre, University of New South Wales</s1>
<s2>Sydney</s2>
<s3>AUS</s3>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>13 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Phillips, Benjamin" sort="Phillips, Benjamin" uniqKey="Phillips B" first="Benjamin" last="Phillips">Benjamin Phillips</name>
<affiliation><inist:fA14 i1="03"><s1>National Drug and Alcohol Research Centre, University of New South Wales</s1>
<s2>Sydney</s2>
<s3>AUS</s3>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>13 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Wiessing, Lucas" sort="Wiessing, Lucas" uniqKey="Wiessing L" first="Lucas" last="Wiessing">Lucas Wiessing</name>
<affiliation><inist:fA14 i1="04"><s1>Crime and Markets Unit, European Monitoring Centre for Drugs and Drug Addiction</s1>
<s2>Lisbon</s2>
<s3>PRT</s3>
<sZ>6 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Hickman, Matthew" sort="Hickman, Matthew" uniqKey="Hickman M" first="Matthew" last="Hickman">Matthew Hickman</name>
<affiliation><inist:fA14 i1="05"><s1>University of Bristol</s1>
<s2>Bristol</s2>
<s3>GBR</s3>
<sZ>7 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Strathdee, Steffanie A" sort="Strathdee, Steffanie A" uniqKey="Strathdee S" first="Steffanie A." last="Strathdee">Steffanie A. Strathdee</name>
<affiliation><inist:fA14 i1="06"><s1>Division of International Health and Cross-Cultural Medicine, University of California</s1>
<s2>San Diego, CA</s2>
<s3>USA</s3>
<sZ>8 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Wodak, Alex" sort="Wodak, Alex" uniqKey="Wodak A" first="Alex" last="Wodak">Alex Wodak</name>
<affiliation><inist:fA14 i1="02"><s1>Secretariat of the Reference Group to the UN on HIV and Injecting Drug Use</s1>
<s3>INC</s3>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>13 aut.</sZ>
</inist:fA14>
</affiliation>
<affiliation><inist:fA14 i1="03"><s1>National Drug and Alcohol Research Centre, University of New South Wales</s1>
<s2>Sydney</s2>
<s3>AUS</s3>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>13 aut.</sZ>
</inist:fA14>
</affiliation>
<affiliation><inist:fA14 i1="07"><s1>Alcohol and Drug Service, St Vincent's Hospital</s1>
<s2>Sydney</s2>
<s3>AUS</s3>
<sZ>9 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Panda, Samiron" sort="Panda, Samiron" uniqKey="Panda S" first="Samiron" last="Panda">Samiron Panda</name>
<affiliation><inist:fA14 i1="08"><s1>National Institute of Cholera and Enteric Diseases (Indian Council of Medical Research) and Society for Positive Atmosphere and Related Support to HIV/AIDS (SPARSHA)</s1>
<s2>West Bengal</s2>
<s3>IND</s3>
<sZ>10 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Tyndall, Mark" sort="Tyndall, Mark" uniqKey="Tyndall M" first="Mark" last="Tyndall">Mark Tyndall</name>
<affiliation><inist:fA14 i1="09"><s1>British Columbia Centre for Excellence in HIV/AIDS</s1>
<s2>Vancouver, BC</s2>
<s3>CAN</s3>
<sZ>11 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Toufik, Abdalla" sort="Toufik, Abdalla" uniqKey="Toufik A" first="Abdalla" last="Toufik">Abdalla Toufik</name>
<affiliation><inist:fA14 i1="10"><s1>Emerging Trends Department, French Monitoring Centre for Drugs and Drug Addiction</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>12 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Mattick, Richard P" sort="Mattick, Richard P" uniqKey="Mattick R" first="Richard P." last="Mattick">Richard P. Mattick</name>
<affiliation><inist:fA14 i1="02"><s1>Secretariat of the Reference Group to the UN on HIV and Injecting Drug Use</s1>
<s3>INC</s3>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>13 aut.</sZ>
</inist:fA14>
</affiliation>
<affiliation><inist:fA14 i1="03"><s1>National Drug and Alcohol Research Centre, University of New South Wales</s1>
<s2>Sydney</s2>
<s3>AUS</s3>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>13 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">INIST</idno>
<idno type="inist">08-0529171</idno>
<date when="2008">2008</date>
<idno type="stanalyst">PASCAL 08-0529171 INIST</idno>
<idno type="RBID">Pascal:08-0529171</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">003184</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Global epidemiology of injecting drug use and HIV among people who inject drugs : a systematic review. Commentary</title>
<author><name sortKey="Arasteh, Kamyar" sort="Arasteh, Kamyar" uniqKey="Arasteh K" first="Kamyar" last="Arasteh">Kamyar Arasteh</name>
<affiliation><inist:fA14 i1="01"><s1>Beth Israel Medical Center, Baron Edmond de Rothschild Chemical Dependency Institute</s1>
<s2>New York, NY 10038</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Des Jarlais, Don C" sort="Des Jarlais, Don C" uniqKey="Des Jarlais D" first="Don C." last="Des Jarlais">Don C. Des Jarlais</name>
<affiliation><inist:fA14 i1="01"><s1>Beth Israel Medical Center, Baron Edmond de Rothschild Chemical Dependency Institute</s1>
<s2>New York, NY 10038</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Mathers, Bradley M" sort="Mathers, Bradley M" uniqKey="Mathers B" first="Bradley M." last="Mathers">Bradley M. Mathers</name>
<affiliation><inist:fA14 i1="02"><s1>Secretariat of the Reference Group to the UN on HIV and Injecting Drug Use</s1>
<s3>INC</s3>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>13 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Degenhardt, Louisa" sort="Degenhardt, Louisa" uniqKey="Degenhardt L" first="Louisa" last="Degenhardt">Louisa Degenhardt</name>
<affiliation><inist:fA14 i1="02"><s1>Secretariat of the Reference Group to the UN on HIV and Injecting Drug Use</s1>
<s3>INC</s3>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>13 aut.</sZ>
</inist:fA14>
</affiliation>
<affiliation><inist:fA14 i1="03"><s1>National Drug and Alcohol Research Centre, University of New South Wales</s1>
<s2>Sydney</s2>
<s3>AUS</s3>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>13 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Phillips, Benjamin" sort="Phillips, Benjamin" uniqKey="Phillips B" first="Benjamin" last="Phillips">Benjamin Phillips</name>
<affiliation><inist:fA14 i1="03"><s1>National Drug and Alcohol Research Centre, University of New South Wales</s1>
<s2>Sydney</s2>
<s3>AUS</s3>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>13 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Wiessing, Lucas" sort="Wiessing, Lucas" uniqKey="Wiessing L" first="Lucas" last="Wiessing">Lucas Wiessing</name>
<affiliation><inist:fA14 i1="04"><s1>Crime and Markets Unit, European Monitoring Centre for Drugs and Drug Addiction</s1>
<s2>Lisbon</s2>
<s3>PRT</s3>
<sZ>6 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Hickman, Matthew" sort="Hickman, Matthew" uniqKey="Hickman M" first="Matthew" last="Hickman">Matthew Hickman</name>
<affiliation><inist:fA14 i1="05"><s1>University of Bristol</s1>
<s2>Bristol</s2>
<s3>GBR</s3>
<sZ>7 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Strathdee, Steffanie A" sort="Strathdee, Steffanie A" uniqKey="Strathdee S" first="Steffanie A." last="Strathdee">Steffanie A. Strathdee</name>
<affiliation><inist:fA14 i1="06"><s1>Division of International Health and Cross-Cultural Medicine, University of California</s1>
<s2>San Diego, CA</s2>
<s3>USA</s3>
<sZ>8 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Wodak, Alex" sort="Wodak, Alex" uniqKey="Wodak A" first="Alex" last="Wodak">Alex Wodak</name>
<affiliation><inist:fA14 i1="02"><s1>Secretariat of the Reference Group to the UN on HIV and Injecting Drug Use</s1>
<s3>INC</s3>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>13 aut.</sZ>
</inist:fA14>
</affiliation>
<affiliation><inist:fA14 i1="03"><s1>National Drug and Alcohol Research Centre, University of New South Wales</s1>
<s2>Sydney</s2>
<s3>AUS</s3>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>13 aut.</sZ>
</inist:fA14>
</affiliation>
<affiliation><inist:fA14 i1="07"><s1>Alcohol and Drug Service, St Vincent's Hospital</s1>
<s2>Sydney</s2>
<s3>AUS</s3>
<sZ>9 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Panda, Samiron" sort="Panda, Samiron" uniqKey="Panda S" first="Samiron" last="Panda">Samiron Panda</name>
<affiliation><inist:fA14 i1="08"><s1>National Institute of Cholera and Enteric Diseases (Indian Council of Medical Research) and Society for Positive Atmosphere and Related Support to HIV/AIDS (SPARSHA)</s1>
<s2>West Bengal</s2>
<s3>IND</s3>
<sZ>10 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Tyndall, Mark" sort="Tyndall, Mark" uniqKey="Tyndall M" first="Mark" last="Tyndall">Mark Tyndall</name>
<affiliation><inist:fA14 i1="09"><s1>British Columbia Centre for Excellence in HIV/AIDS</s1>
<s2>Vancouver, BC</s2>
<s3>CAN</s3>
<sZ>11 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Toufik, Abdalla" sort="Toufik, Abdalla" uniqKey="Toufik A" first="Abdalla" last="Toufik">Abdalla Toufik</name>
<affiliation><inist:fA14 i1="10"><s1>Emerging Trends Department, French Monitoring Centre for Drugs and Drug Addiction</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>12 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Mattick, Richard P" sort="Mattick, Richard P" uniqKey="Mattick R" first="Richard P." last="Mattick">Richard P. Mattick</name>
<affiliation><inist:fA14 i1="02"><s1>Secretariat of the Reference Group to the UN on HIV and Injecting Drug Use</s1>
<s3>INC</s3>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>13 aut.</sZ>
</inist:fA14>
</affiliation>
<affiliation><inist:fA14 i1="03"><s1>National Drug and Alcohol Research Centre, University of New South Wales</s1>
<s2>Sydney</s2>
<s3>AUS</s3>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>13 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
</analytic>
<series><title level="j" type="main">Lancet : (British edition)</title>
<title level="j" type="abbreviated">Lancet : (Br. ed.)</title>
<idno type="ISSN">0140-6736</idno>
<imprint><date when="2008">2008</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><title level="j" type="main">Lancet : (British edition)</title>
<title level="j" type="abbreviated">Lancet : (Br. ed.)</title>
<idno type="ISSN">0140-6736</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>AIDS</term>
<term>Drug</term>
<term>Drug addiction</term>
<term>Epidemiology</term>
<term>Human</term>
<term>Human immunodeficiency virus</term>
<term>Intravenous administration</term>
<term>Medicine</term>
<term>Public health</term>
<term>Systematic review</term>
<term>WHO</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Toxicomanie</term>
<term>Epidémiologie</term>
<term>Santé publique</term>
<term>Voie intraveineuse</term>
<term>Virus immunodéficience humaine</term>
<term>SIDA</term>
<term>OMS</term>
<term>Médicament</term>
<term>Revue systématique</term>
<term>Médecine</term>
<term>Homme</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Background Injecting drug use is an increasingly important cause of HIV transmission in most countries worldwide. Our aim was to determine the prevalence of injecting drug use among individuals aged 15-64 years, and of HIV among people who inject drugs. Methods We did a systematic search of peer-reviewed (Medline, EmBase, and PubMed/BioMed Central), internet, and grey literature databases; and data requests were made to UN agencies and international experts. 11022 documents were reviewed, graded, and catalogued by the Reference Group to the UN on HIV and Injecting Drug Use. Findings Injecting drug use was identified in 148 countries; data for the extent of injecting drug use was absent for many countries in Africa, the Middle East, and Latin America. The presence of HIV infection among injectors had been reported in 120 of these countries. Prevalence estimates of injecting drug use could be ascertained for 61 countries, containing 77% of the world's total population aged 15-64 years. Extrapolated estimates suggest that 15.9 million (range 11 .0-21 .2 million) people might inject drugs worldwide; the largest numbers of injectors were found in China, the USA, and Russia, where mid-estimates of HIV prevalence among injectors were 12%, 16%, and 37%, respectively. HIV prevalence among injecting drug users was 20-40% in five countries and over 40% in nine. We estimate that, worldwide, about 3. 0 million (range 0. 8-6.6 million) people who inject drugs might be HIV positive. Interpretation The number of countries in which the injection of drugs has been reported has increased over the last decade. The high prevalence of HIV among many populations of injecting drug users represents a substantial global health challenge. However, existing data are far from adequate, in both quality and quantity, particularly in view of the increasing importance of injecting drug use as a mode of HIV transmission in many regions.</div>
</front>
</TEI>
<inist><standard h6="B"><pA><fA01 i1="01" i2="1"><s0>0140-6736</s0>
</fA01>
<fA02 i1="01"><s0>LANCAO</s0>
</fA02>
<fA03 i2="1"><s0>Lancet : (Br. ed.)</s0>
</fA03>
<fA05><s2>372</s2>
</fA05>
<fA06><s2>9651</s2>
</fA06>
<fA08 i1="01" i2="1" l="ENG"><s1>Global epidemiology of injecting drug use and HIV among people who inject drugs : a systematic review. Commentary</s1>
</fA08>
<fA11 i1="01" i2="1"><s1>ARASTEH (Kamyar)</s1>
<s9>comment.</s9>
</fA11>
<fA11 i1="02" i2="1"><s1>DES JARLAIS (Don C.)</s1>
<s9>comment.</s9>
</fA11>
<fA11 i1="03" i2="1"><s1>MATHERS (Bradley M.)</s1>
</fA11>
<fA11 i1="04" i2="1"><s1>DEGENHARDT (Louisa)</s1>
</fA11>
<fA11 i1="05" i2="1"><s1>PHILLIPS (Benjamin)</s1>
</fA11>
<fA11 i1="06" i2="1"><s1>WIESSING (Lucas)</s1>
</fA11>
<fA11 i1="07" i2="1"><s1>HICKMAN (Matthew)</s1>
</fA11>
<fA11 i1="08" i2="1"><s1>STRATHDEE (Steffanie A.)</s1>
</fA11>
<fA11 i1="09" i2="1"><s1>WODAK (Alex)</s1>
</fA11>
<fA11 i1="10" i2="1"><s1>PANDA (Samiron)</s1>
</fA11>
<fA11 i1="11" i2="1"><s1>TYNDALL (Mark)</s1>
</fA11>
<fA11 i1="12" i2="1"><s1>TOUFIK (Abdalla)</s1>
</fA11>
<fA11 i1="13" i2="1"><s1>MATTICK (Richard P.)</s1>
</fA11>
<fA14 i1="01"><s1>Beth Israel Medical Center, Baron Edmond de Rothschild Chemical Dependency Institute</s1>
<s2>New York, NY 10038</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
</fA14>
<fA14 i1="02"><s1>Secretariat of the Reference Group to the UN on HIV and Injecting Drug Use</s1>
<s3>INC</s3>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>13 aut.</sZ>
</fA14>
<fA14 i1="03"><s1>National Drug and Alcohol Research Centre, University of New South Wales</s1>
<s2>Sydney</s2>
<s3>AUS</s3>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>13 aut.</sZ>
</fA14>
<fA14 i1="04"><s1>Crime and Markets Unit, European Monitoring Centre for Drugs and Drug Addiction</s1>
<s2>Lisbon</s2>
<s3>PRT</s3>
<sZ>6 aut.</sZ>
</fA14>
<fA14 i1="05"><s1>University of Bristol</s1>
<s2>Bristol</s2>
<s3>GBR</s3>
<sZ>7 aut.</sZ>
</fA14>
<fA14 i1="06"><s1>Division of International Health and Cross-Cultural Medicine, University of California</s1>
<s2>San Diego, CA</s2>
<s3>USA</s3>
<sZ>8 aut.</sZ>
</fA14>
<fA14 i1="07"><s1>Alcohol and Drug Service, St Vincent's Hospital</s1>
<s2>Sydney</s2>
<s3>AUS</s3>
<sZ>9 aut.</sZ>
</fA14>
<fA14 i1="08"><s1>National Institute of Cholera and Enteric Diseases (Indian Council of Medical Research) and Society for Positive Atmosphere and Related Support to HIV/AIDS (SPARSHA)</s1>
<s2>West Bengal</s2>
<s3>IND</s3>
<sZ>10 aut.</sZ>
</fA14>
<fA14 i1="09"><s1>British Columbia Centre for Excellence in HIV/AIDS</s1>
<s2>Vancouver, BC</s2>
<s3>CAN</s3>
<sZ>11 aut.</sZ>
</fA14>
<fA14 i1="10"><s1>Emerging Trends Department, French Monitoring Centre for Drugs and Drug Addiction</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>12 aut.</sZ>
</fA14>
<fA17 i1="01" i2="1"><s1>2007 Reference Group to the UN on HIV and Injecting Drug Use</s1>
<s3>INC</s3>
</fA17>
<fA20><s2>1709-1710, 1733-1745 [15 p.]</s2>
</fA20>
<fA21><s1>2008</s1>
</fA21>
<fA23 i1="01"><s0>ENG</s0>
</fA23>
<fA43 i1="01"><s1>INIST</s1>
<s2>5004</s2>
<s5>354000184296890100</s5>
</fA43>
<fA44><s0>0000</s0>
<s1>© 2008 INIST-CNRS. All rights reserved.</s1>
</fA44>
<fA45><s0>34 ref.</s0>
</fA45>
<fA47 i1="01" i2="1"><s0>08-0529171</s0>
</fA47>
<fA60><s1>P</s1>
<s3>AR</s3>
<s3>CT</s3>
</fA60>
<fA61><s0>A</s0>
</fA61>
<fA64 i1="01" i2="1"><s0>Lancet : (British edition)</s0>
</fA64>
<fA66 i1="01"><s0>GBR</s0>
</fA66>
<fC01 i1="01" l="ENG"><s0>Background Injecting drug use is an increasingly important cause of HIV transmission in most countries worldwide. Our aim was to determine the prevalence of injecting drug use among individuals aged 15-64 years, and of HIV among people who inject drugs. Methods We did a systematic search of peer-reviewed (Medline, EmBase, and PubMed/BioMed Central), internet, and grey literature databases; and data requests were made to UN agencies and international experts. 11022 documents were reviewed, graded, and catalogued by the Reference Group to the UN on HIV and Injecting Drug Use. Findings Injecting drug use was identified in 148 countries; data for the extent of injecting drug use was absent for many countries in Africa, the Middle East, and Latin America. The presence of HIV infection among injectors had been reported in 120 of these countries. Prevalence estimates of injecting drug use could be ascertained for 61 countries, containing 77% of the world's total population aged 15-64 years. Extrapolated estimates suggest that 15.9 million (range 11 .0-21 .2 million) people might inject drugs worldwide; the largest numbers of injectors were found in China, the USA, and Russia, where mid-estimates of HIV prevalence among injectors were 12%, 16%, and 37%, respectively. HIV prevalence among injecting drug users was 20-40% in five countries and over 40% in nine. We estimate that, worldwide, about 3. 0 million (range 0. 8-6.6 million) people who inject drugs might be HIV positive. Interpretation The number of countries in which the injection of drugs has been reported has increased over the last decade. The high prevalence of HIV among many populations of injecting drug users represents a substantial global health challenge. However, existing data are far from adequate, in both quality and quantity, particularly in view of the increasing importance of injecting drug use as a mode of HIV transmission in many regions.</s0>
</fC01>
<fC02 i1="01" i2="X"><s0>002B01</s0>
</fC02>
<fC02 i1="02" i2="X"><s0>002B30A01A</s0>
</fC02>
<fC02 i1="03" i2="X"><s0>002B30A11</s0>
</fC02>
<fC03 i1="01" i2="X" l="FRE"><s0>Toxicomanie</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="ENG"><s0>Drug addiction</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="SPA"><s0>Toxicomanía</s0>
<s5>01</s5>
</fC03>
<fC03 i1="02" i2="X" l="FRE"><s0>Epidémiologie</s0>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="ENG"><s0>Epidemiology</s0>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="SPA"><s0>Epidemiología</s0>
<s5>02</s5>
</fC03>
<fC03 i1="03" i2="X" l="FRE"><s0>Santé publique</s0>
<s5>03</s5>
</fC03>
<fC03 i1="03" i2="X" l="ENG"><s0>Public health</s0>
<s5>03</s5>
</fC03>
<fC03 i1="03" i2="X" l="SPA"><s0>Salud pública</s0>
<s5>03</s5>
</fC03>
<fC03 i1="04" i2="X" l="FRE"><s0>Voie intraveineuse</s0>
<s5>05</s5>
</fC03>
<fC03 i1="04" i2="X" l="ENG"><s0>Intravenous administration</s0>
<s5>05</s5>
</fC03>
<fC03 i1="04" i2="X" l="SPA"><s0>Vía intravenosa</s0>
<s5>05</s5>
</fC03>
<fC03 i1="05" i2="X" l="FRE"><s0>Virus immunodéficience humaine</s0>
<s2>NW</s2>
<s5>06</s5>
</fC03>
<fC03 i1="05" i2="X" l="ENG"><s0>Human immunodeficiency virus</s0>
<s2>NW</s2>
<s5>06</s5>
</fC03>
<fC03 i1="05" i2="X" l="SPA"><s0>Human immunodeficiency virus</s0>
<s2>NW</s2>
<s5>06</s5>
</fC03>
<fC03 i1="06" i2="X" l="FRE"><s0>SIDA</s0>
<s5>08</s5>
</fC03>
<fC03 i1="06" i2="X" l="ENG"><s0>AIDS</s0>
<s5>08</s5>
</fC03>
<fC03 i1="06" i2="X" l="SPA"><s0>SIDA</s0>
<s5>08</s5>
</fC03>
<fC03 i1="07" i2="X" l="FRE"><s0>OMS</s0>
<s5>09</s5>
</fC03>
<fC03 i1="07" i2="X" l="ENG"><s0>WHO</s0>
<s5>09</s5>
</fC03>
<fC03 i1="07" i2="X" l="SPA"><s0>OMS</s0>
<s5>09</s5>
</fC03>
<fC03 i1="08" i2="X" l="FRE"><s0>Médicament</s0>
<s5>11</s5>
</fC03>
<fC03 i1="08" i2="X" l="ENG"><s0>Drug</s0>
<s5>11</s5>
</fC03>
<fC03 i1="08" i2="X" l="SPA"><s0>Medicamento</s0>
<s5>11</s5>
</fC03>
<fC03 i1="09" i2="X" l="FRE"><s0>Revue systématique</s0>
<s2>FM</s2>
<s5>12</s5>
</fC03>
<fC03 i1="09" i2="X" l="ENG"><s0>Systematic review</s0>
<s2>FM</s2>
<s5>12</s5>
</fC03>
<fC03 i1="09" i2="X" l="SPA"><s0>Revisión sistemática</s0>
<s2>FM</s2>
<s5>12</s5>
</fC03>
<fC03 i1="10" i2="X" l="FRE"><s0>Médecine</s0>
<s5>17</s5>
</fC03>
<fC03 i1="10" i2="X" l="ENG"><s0>Medicine</s0>
<s5>17</s5>
</fC03>
<fC03 i1="10" i2="X" l="SPA"><s0>Medicina</s0>
<s5>17</s5>
</fC03>
<fC03 i1="11" i2="X" l="FRE"><s0>Homme</s0>
<s5>18</s5>
</fC03>
<fC03 i1="11" i2="X" l="ENG"><s0>Human</s0>
<s5>18</s5>
</fC03>
<fC03 i1="11" i2="X" l="SPA"><s0>Hombre</s0>
<s5>18</s5>
</fC03>
<fC07 i1="01" i2="X" l="FRE"><s0>Lentivirus</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="01" i2="X" l="ENG"><s0>Lentivirus</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="01" i2="X" l="SPA"><s0>Lentivirus</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="02" i2="X" l="FRE"><s0>Retroviridae</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="02" i2="X" l="ENG"><s0>Retroviridae</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="02" i2="X" l="SPA"><s0>Retroviridae</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="03" i2="X" l="FRE"><s0>Virus</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="03" i2="X" l="ENG"><s0>Virus</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="03" i2="X" l="SPA"><s0>Virus</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="04" i2="X" l="FRE"><s0>Virose</s0>
</fC07>
<fC07 i1="04" i2="X" l="ENG"><s0>Viral disease</s0>
</fC07>
<fC07 i1="04" i2="X" l="SPA"><s0>Virosis</s0>
</fC07>
<fC07 i1="05" i2="X" l="FRE"><s0>Infection</s0>
</fC07>
<fC07 i1="05" i2="X" l="ENG"><s0>Infection</s0>
</fC07>
<fC07 i1="05" i2="X" l="SPA"><s0>Infección</s0>
</fC07>
<fC07 i1="06" i2="X" l="FRE"><s0>Immunodéficit</s0>
<s5>37</s5>
</fC07>
<fC07 i1="06" i2="X" l="ENG"><s0>Immune deficiency</s0>
<s5>37</s5>
</fC07>
<fC07 i1="06" i2="X" l="SPA"><s0>Inmunodeficiencia</s0>
<s5>37</s5>
</fC07>
<fC07 i1="07" i2="X" l="FRE"><s0>Immunopathologie</s0>
<s5>39</s5>
</fC07>
<fC07 i1="07" i2="X" l="ENG"><s0>Immunopathology</s0>
<s5>39</s5>
</fC07>
<fC07 i1="07" i2="X" l="SPA"><s0>Inmunopatología</s0>
<s5>39</s5>
</fC07>
<fN21><s1>350</s1>
</fN21>
</pA>
</standard>
<server><NO>PASCAL 08-0529171 INIST</NO>
<ET>Global epidemiology of injecting drug use and HIV among people who inject drugs : a systematic review. Commentary</ET>
<AU>ARASTEH (Kamyar); DES JARLAIS (Don C.); MATHERS (Bradley M.); DEGENHARDT (Louisa); PHILLIPS (Benjamin); WIESSING (Lucas); HICKMAN (Matthew); STRATHDEE (Steffanie A.); WODAK (Alex); PANDA (Samiron); TYNDALL (Mark); TOUFIK (Abdalla); MATTICK (Richard P.)</AU>
<AF>Beth Israel Medical Center, Baron Edmond de Rothschild Chemical Dependency Institute/New York, NY 10038/Etats-Unis (1 aut., 2 aut.); Secretariat of the Reference Group to the UN on HIV and Injecting Drug Use/Inconnu (3 aut., 4 aut., 9 aut., 13 aut.); National Drug and Alcohol Research Centre, University of New South Wales/Sydney/Australie (4 aut., 5 aut., 9 aut., 13 aut.); Crime and Markets Unit, European Monitoring Centre for Drugs and Drug Addiction/Lisbon/Portugal (6 aut.); University of Bristol/Bristol/Royaume-Uni (7 aut.); Division of International Health and Cross-Cultural Medicine, University of California/San Diego, CA/Etats-Unis (8 aut.); Alcohol and Drug Service, St Vincent's Hospital/Sydney/Australie (9 aut.); National Institute of Cholera and Enteric Diseases (Indian Council of Medical Research) and Society for Positive Atmosphere and Related Support to HIV/AIDS (SPARSHA)/West Bengal/Inde (10 aut.); British Columbia Centre for Excellence in HIV/AIDS/Vancouver, BC/Canada (11 aut.); Emerging Trends Department, French Monitoring Centre for Drugs and Drug Addiction/Paris/France (12 aut.)</AF>
<DT>Publication en série; Article; Commentaire; Niveau analytique</DT>
<SO>Lancet : (British edition); ISSN 0140-6736; Coden LANCAO; Royaume-Uni; Da. 2008; Vol. 372; No. 9651; 1709-1710, 1733-1745 [15 p.]; Bibl. 34 ref.</SO>
<LA>Anglais</LA>
<EA>Background Injecting drug use is an increasingly important cause of HIV transmission in most countries worldwide. Our aim was to determine the prevalence of injecting drug use among individuals aged 15-64 years, and of HIV among people who inject drugs. Methods We did a systematic search of peer-reviewed (Medline, EmBase, and PubMed/BioMed Central), internet, and grey literature databases; and data requests were made to UN agencies and international experts. 11022 documents were reviewed, graded, and catalogued by the Reference Group to the UN on HIV and Injecting Drug Use. Findings Injecting drug use was identified in 148 countries; data for the extent of injecting drug use was absent for many countries in Africa, the Middle East, and Latin America. The presence of HIV infection among injectors had been reported in 120 of these countries. Prevalence estimates of injecting drug use could be ascertained for 61 countries, containing 77% of the world's total population aged 15-64 years. Extrapolated estimates suggest that 15.9 million (range 11 .0-21 .2 million) people might inject drugs worldwide; the largest numbers of injectors were found in China, the USA, and Russia, where mid-estimates of HIV prevalence among injectors were 12%, 16%, and 37%, respectively. HIV prevalence among injecting drug users was 20-40% in five countries and over 40% in nine. We estimate that, worldwide, about 3. 0 million (range 0. 8-6.6 million) people who inject drugs might be HIV positive. Interpretation The number of countries in which the injection of drugs has been reported has increased over the last decade. The high prevalence of HIV among many populations of injecting drug users represents a substantial global health challenge. However, existing data are far from adequate, in both quality and quantity, particularly in view of the increasing importance of injecting drug use as a mode of HIV transmission in many regions.</EA>
<CC>002B01; 002B30A01A; 002B30A11</CC>
<FD>Toxicomanie; Epidémiologie; Santé publique; Voie intraveineuse; Virus immunodéficience humaine; SIDA; OMS; Médicament; Revue systématique; Médecine; Homme</FD>
<FG>Lentivirus; Retroviridae; Virus; Virose; Infection; Immunodéficit; Immunopathologie</FG>
<ED>Drug addiction; Epidemiology; Public health; Intravenous administration; Human immunodeficiency virus; AIDS; WHO; Drug; Systematic review; Medicine; Human</ED>
<EG>Lentivirus; Retroviridae; Virus; Viral disease; Infection; Immune deficiency; Immunopathology</EG>
<SD>Toxicomanía; Epidemiología; Salud pública; Vía intravenosa; Human immunodeficiency virus; SIDA; OMS; Medicamento; Revisión sistemática; Medicina; Hombre</SD>
<LO>INIST-5004.354000184296890100</LO>
<ID>08-0529171</ID>
</server>
</inist>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/PascalFrancis/Corpus

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003184 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Corpus/biblio.hfd -nk 003184 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Asie
   |area=    AustralieFrV1
   |flux=    PascalFrancis
   |étape=   Corpus
   |type=    RBID
   |clé=     Pascal:08-0529171
   |texte=   Global epidemiology of injecting drug use and HIV among people who inject drugs : a systematic review. Commentary
}}

This area was generated with Dilib version V0.6.33.
Data generation: Tue Dec 5 10:43:12 2017. Site generation: Tue Mar 5 14:07:20 2024

	Serveur d'exploration sur les relations entre la France et l'Australie
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration sur les relations entre la France et l'Australie

Global epidemiology of injecting drug use and HIV among people who inject drugs : a systematic review. Commentary

Global epidemiology of injecting drug use and HIV among people who inject drugs : a systematic review. Commentary

Source :

Descripteurs français

English descriptors

Abstract

Notice en format standard (ISO 2709)

Format Inist (serveur)

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri